홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /화합물

Fructose-1,6-Diphosphate

HCID 445557
새 노트새 반응견적 요청하기
인쇄 미리보기

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
34693-23-7
표준 SMILES
O=P(O)(O)OC[C@H]1O[C@@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O
InChIKey
RNBGYGVWRKECFJ-ZXXMMSQZSA-N
분자식
C6H14O12P2
평균 분자량
340.12 g/mol

개요

Alpha-D-fructofuranose 1,6-bisphosphate is a D-fructofuranose 1,6-bisphosphate with an alpha-configuration at the anomeric position. It is functionally related to an alpha-D-fructofuranose. It is a conjugate acid of an alpha-D-fructofuranose 1,6-bisphosphate(4-).

이름 및 식별자

우선 이름
Fructose-1,6-Diphosphate
IUPAC
[(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate

이름 및 동의어

fructose-1,6-diphosphateFructose 1,6-diphosphate[(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate((2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl)methyl dihydrogen phosphateSr-FDPRefChem:600595GlyTouCan:G18745STstrontium fructose-1,6-diphosphateG18745STANW5CM3PJ7alpha-D-FosfructofuranoseUNII-ANW5CM3PJ7
이름 더 보기
NSC-575531,6-di-O-phosphono-alpha-D-fructofuranoseCHEMBL1089962alpha-D-Fructofuranose 1,6-diphosphatealpha-D-fructofuranose 1,6-bisphosphatealpha-D-Fructofuranose, 1,6-bis(dihydrogen phosphate)fructose-1,6-bisphosphateAFP

데이터베이스 식별자

CAS
34693-23-7
PubChem CID
445557
ChEMBL
CHEMBL1089962
ChEBI
CHEBI:40595
UNII
ANW5CM3PJ7
Nikkaji
J792.775D

물성

구조 계산 물성보충 중

XLogP
-5.6
극성 표면적
203 Ų
수소 결합 공여자 수
7
수소 결합 수용자 수
12
회전 가능 결합 수
6
무거운 원자 수
20
형식 전하
0
복잡도
428

실험 및 물리화학적 성질

Collision Cross Section168.2 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

화학 및 산업

약리 정보

ATC Code · 2건

C - Cardiovascular system

QC - Cardiovascular system

MeSH Pharmacological Classification · 4건

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.

Biologically active substances whose activities affect or play a role in the functioning of the immune system.

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.

관련 반응

3건
반응 기록 만들기
HRID 991168 반응식
HRID 991168반응물로uspto-grants-2002_10
HRID 2227142 반응식
HRID 2227142반응물로uspto-grants-2002_07
HRID 2371662 반응식
HRID 2371662생성물로반응물로uspto-grants-1992_03

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
더보기
새 노트새 반응견적 요청하기